Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
357 studies found for:    shingles

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
2 Completed Shingles Prevention Study
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine;   Biological: Placebo
3 Completed Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Condition: Herpes Zoster Disease
Intervention: Other: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
4 Active, not recruiting ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: ZOSTAVAX™
5 Recruiting Optimal Timing of Zoster Vaccine After Zoster Illness
Condition: Shingles
Intervention: Biological: Zostavax
6 Active, not recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo
7 Completed
Has Results 		Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly
Condition: Shingles
Intervention: Biological: ZOSTAVAX
8 Completed A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
9 Completed
Has Results 		Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
Conditions: Herpes Zoster;   Varicella-zoster Vaccine
Intervention: Biological: Zoster Vaccine, Live
10 Recruiting Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine
Condition: Healthy
Intervention: Biological: Live-attenuated varicella-zoster virus vaccine
11 Active, not recruiting Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Conditions: Immunosenescence;   Shingles
Intervention: Biological: Varicella Zoster Virus Vaccine (Zostavax)
12 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
13 Completed Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects
Conditions: Herpes Zoster (Shingles);   Shingles
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
14 Recruiting Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
Condition: Psoriasis
Interventions: Drug: Varicella Zoster Vaccine;   Drug: Placebo
15 Recruiting A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
16 Active, not recruiting Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
17 Completed Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo vaccine (saline)
18 Unknown † T Cell Responses to Varicella Zoster Virus (VZV)
Condition: Immune Response to Zoster Vaccine
Intervention: Biological: Zostavax™
19 Completed Shingles: Immune Effects of Tai Chi
Conditions: Aging;   Herpes Zoster
Intervention: Behavioral: Tai Chi Chih
20 Completed
Has Results 		A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Condition: Herpes Zoster
Interventions: Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation;   Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulation
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years